Live Quote · NASDAQABVXHealthcare· Biotechnology

Abivax S.A.

$73.20▼ 9.24%($-7.45)
MKT CAP $6.41BNEXT EARNINGS Dec 21, 2026
50%
Bullish
TickerSpark Score
48/100
▌ Weak
53
Valuation
60
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABVX research report →

Analyst Price Target
$156.00+113.1% vs. today

Range $118 – $180

Analyst RatingBuy
12 Buy1 Hold0 Sell

Price Chart

-35.37% · this period
$145.31$108.91$72.50Nov 20May 26Nov 20
52-Week Range12% of range
Low
$62.97
Current
$73.20
High
$148.83

AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice